Practice Direction Refill History Recording System

Similar documents
Practice Direction Standard of Practice # 5: Administration of Drugs including Vaccines

View/Enter Patient Record. 3.1 CP-UC1-PS1 Refill Prescription (CASH)

SECTION PRESCRIPTIONS

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

Guideline for the Rational Use of Controlled Drugs

Destruction of Narcotics, Controlled Drugs and other Targeted Substances

Guidance on Bulk Prescribing for Care Home Patients

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

What Do IACP Members Think?

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999

Michigan Opioid Legislation Hospital Compliance Checklist

Nova Scotia Drug Information System

AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

Do not open the test booklet prior to being told to do so.

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

Prescribing and Dispensing Drugs

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

User Guide for Transition to the Drug Information System

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

General Providers. Tamper-Resistant Prescription Requirements

Prescription Monitoring Program (PMP)

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

States with Authority to Require Nonresident Pharmacies to Report to PMP

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

This Chapter Contains:

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

H 7816 S T A T E O F R H O D E I S L A N D

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

IMPAACT MOCHA More Options for Children and Adolescents

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

The New Veterinary Feed Directive (VFD) Rule. Timothy S. Kniffen DVM, MS Merck Animal Health North American Aquaculture Business Unit

Please find enclosed Dosimetry Service Licence No which replaces Dosimetry Service Licence No

Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting

KANSAS MEDICAL ASSISTANCE PROGRAM. Fee-for-Service Provider Manual. Rehabilitative Therapy Services

Guidance on Bulk Prescribing for Care Home Residents

Controlled Substances Program. For Academic Units

Patient Agreement for the use of Opioid Medications

Prescribing Controlled Substances and the PDMP

Guidance for the Network Review of Chemotherapy Errors

PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL

PRESCRIPTION DRUG MONITORING PROGRAM

Coventry Health Care of Georgia, Inc.

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease

Hazard Communication Program. Santa Clara University (SCU) 500 El Camino Real Santa Clara, CA 95053

NATPARA (parathyroid hormone) for injection Risk Evaluation and Mitigation Strategy (REMS) Program

Alabama Medicaid Pharmacy Override

North Dakota Board of Pharmacy

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Sub. S.B. 119 As Passed by the Senate

PCC EHR Meaningful Use Measures. Maria Horn July 18, :15 pm. Including CQM Reports

New York. Prescribing and Dispensing Profile. Research current through November 2015.

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008

New regulatory requirements DPCS Regulations 2017

60A-1 Regulation of massage establishment or premises.

Regulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices

Refilling a Prescription with No Refills Remaining

Instructions for Applicants. Successful completion of this examination is required as one of the conditions for licensure in the State of Vermont.

DIPLOMA IN SPECIAL CARE DENTISTRY

Methadone 8.3. Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures.

Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

2016 Dr. Douglas H. Kay CPE Symposium

Colorado State Board of Medical Examiners Policy

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE

PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Arkansas Department of Health

Knowledge Based Qualification for the NVQ3 (QCF) Diploma in Pharmacy Service Skills. Master Forms

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy

Chemotherapy Training and Assessment Policy. For Medical Prescribers and Pharmacy Verifiers

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

MEDICAL COUNCIL OF NSW

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE BOARD OF PHYSICAL THERAPY GENERAL RULES

FlexRx 6-Tier. SM Pharmacy Benefit Guide

Fencino patch (5) 2. Check the practice has agreed to the protocol and a signed copy is in place.

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

2017 Legislative Policy Update

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

Pharmacy Audit Recovery Guidelines

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Controlled Substances Program Procedures. UC Merced Environmental Health and Safety August 2015

Dispensing and administration of emergency opioid antagonist without a

Kansas Department of Revenue. September 22, Revenue Ruling No

Transcription:

1.0 Scope and Objective: 1.1 Expected Outcome Practice Direction Refill History Recording System This document is a practice direction by Council concerning implementation of concept of prescription refill recording systems through the authority of The Pharmaceutical Regulations to The Pharmaceutical Act and The Pharmaceutical Act. These systems may be used for all prescriptions, including targeted substances and other benzodiazepines, but not narcotic or controlled medication. 1.2 Document Jurisdiction (Area of Practice) Standard of Practice 12 of the Regulations to The Pharmaceutical Act of Manitoba states that a member and an owner must create, maintain and retain records as required under the Act and regulations and in a form and manner that allows them to be accessed as promptly as needed. 1.3 Regulatory Authority Reference 2.0 Practice Direction Sections 56(1) and 56(2) of the Regulation to the Act allows Council to create this practice direction. 2.1 Community Practice 2.1.1 A New Prescription With Refills Indicated: 2.1.1.1 Once a new prescription has been presented at a pharmacy for filling, the prescription information is then entered into a computer system that will maintain a readily accessible patient profile. At the time of entry of the prescription, the number of refills authorized by the prescriber is entered as well. If the refill authorization is indicated as a passage of time (e.g. refill for one year), that must be reflected by the information indicated in the computer and not simply indicated as being refillable a number of times (that would presumably be equivalent to that passage of time).

2.1.1.2 Refills authorized for targeted substances (benzodiazepines) are only valid for one year from the date of the original prescription and it would be desirable that the computer system must support this restriction. 2.1.2 A New Prescription With No Refills Indicated: 2.1.2.1 The new prescription is entered into the computer system that maintains a readily accessible patient profile and if there are no refills authorized, the prescription cannot be refilled. Should the patient return to the pharmacy, request a refill of that particular prescription and the prescriber is subsequently contacted and authorizes a "refill", a new prescription number and a new hard copy prescription must be generated and placed on the prescription file. 2.1.2.1.1 A Continued Care prescription issued by a pharmacist is considered a new prescription, not a refill prescription; a new prescription record must be prepared, with the pharmacist as the prescriber. 2.1.3 Record of Refills Under Above Section 2.1.1: 2.1.3.1 The refill of a prescription described in section 2.1.1 and elaborated on in sections 2.1.4.2 and 2.1.4.3 can be done without referring back to the original hard copy prescription if the pharmacist refilling the prescription is certain the information contained in the computer system is a true representation of the information on the original hard copy prescription. 2.1.4 Recording the Refill Information - Documentation of the prescription refill can be done utilizing one of the following systems: 2.1.4.1 Original Prescription File - Documentation of the prescription refill can be done on the original hardcopy prescription and would include: 2.1.4.1.1 Date of dispensing ; 2.1.4.1.2 Quantity dispensed; 2.1.4.1.3 Price charged (if different from previous dispensing); 2.1.4.1.4 Handwritten signature or initials of the pharmacist dispensing the prescription; 2.1.4.1.5 Manufacturer's product used.

2.1.4.2 Logbook Recording System The computer system must maintain the refill history of the prescriptions and the following refill information must be recorded in a hardcopy log book: 2.1.4.2.1 date of dispensing; 2.1.4.2.2 prescription number; 2.1.4.2.3 quantity dispensed; 2.1.4.2.4 handwritten signature or initials of the pharmacist dispensing the prescription; 2.1.4.2.5 price charged. 2.1.4.2.6 The logbook utilized must comply with the following requirements: 2.1.4.2.6.1 neat and orderly; 2.1.4.2.6.2 refill information must be listed in column form; 2.1.4.2.6.3 refill information must be clearly separated by date; 2.1.4.2.6.4 pages are separated by month and by year; 2.1.4.2.6.5 must contain refill prescriptions and may contain first fill prescriptions, and noted as such; 2.1.4.2.6.6 must be retained for two years beyond last refill date. 2.1.4.3 Transaction Refill System - The computer must generate an original or electronic copy refill prescription displaying all the pertinent information of the original prescription in compliance with section 70(1) of the regulations to the Pharmaceutical Act and maintain the prescription number of the original prescription. The "new" refill prescription will have a unique transaction number assigned to the hard copy; 2.1.4.3.1 The refill prescription transaction hard copy must display the original or electronic signature or initials of the pharmacist dispensing the prescription; 2.1.4.3.2 The prescription file in the pharmacy would be filed chronologically by transaction numbers or chronologically by date. The files would contain all new (with original written prescription attached, when available) and refill

transaction hard copies, filed together or separately, in a readily retrievable manner. 2.1.5 Retention of Records - Under section 79(1) of the regulations to the Pharmaceutical Act, records may be recorded and retained in either an electronic or written form. If a record requires a signature or an initial then it must be an original or electronic signature or initial. Prescription records must be retained for a period of at least five years either electronically or in written form. A scanned original and stored electronic copy would comply with section 79(1) of the regulations to the Pharmaceutical Act. 2.2 Personal Care Home Practice: 2.2.1 Where medications are provided for residents of personal care homes and the renewal authorizations come from the Quarter Medication Review sheets (QMR), these QMRS must be filed in a readily retrievable manner for the period of time required by law. 2.2.2 Where medications are provided for residents of personal care homes utilizing a printed daily log file, which is signed by the dispensing pharmacist, the daily log file can display both new and refill information (i.e. section 2.1.4.2 of this document would not apply). 2.2.3 In addition to the above two points, Personal Care Home pharmacy practice must be compliant with Community Practice Points 2.1 through 2.1.5. 2.3 Hospital Practice: 2.3.1 Hospital outpatient prescription refill recording systems must comply with this document. In patient prescription refill systems must be consistent with the Policy and Procedures established by the institution. 3.0 Compliance Adjudication 3.1 All documentation must be readily accessible and open to regulatory review 4.0 Appendices Not applicable A College Practice Direction is a written statement made by Council for the purposes of giving direction to members and owners about the conduct of their practice or pharmacy operations. Compliance with practice directions is required under the Pharmaceutical Act.

The process for development, consultation, implementation, appeal and review has been published on the MPhA website. Development Source: Standards of Practice Committee Regulatory Reference: Section 56 The Pharmaceutical Regulations Consultation Close: January 26, 2015 Authorized by Council: February 9, 2015 Effective Date: March 1, 2015 Revised: Review Due: